What they were paid
Sana Biotechnology Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $20,488 | $0 | $0 | $0 | $20,488 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sana Biotechnology, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-174883, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Sana Biotechnology pays directors a $40,000 cash retainer and $122,787 in equity.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Sana Biotechnology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alise S. Reicin, M.D | Independent Director | $170,287 |
| Hans E. Bishop | Chair of the Board | $220,515 |
| Joshua H. Bilenker, M.D | Independent Director | $169,517 |
| Michelle Seitz, CFA | Independent Director | $182,787 |
| Patrick Y. Yang, Ph.D | Independent Director | $167,787 |
| Richard Mulligan, Ph.D | Director | $162,787 |
| Robert L. Rosiello | Independent Director | $230,696 |
| Robert Nelsen | Independent Director | $162,787 |
| Steven D. Harr, M.D | Director | $0 |
The full Sana Biotechnology compensation record
free company briefThis page is one director within Sana Biotechnology's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat